Published online by Cambridge University Press: 03 December 2009
Cultural property activists have worried about the bioprospecting, or even biopiracy, of kava (Piper methysticum), a plant exchanged and consumed for many Pacific social and ritual purposes. By the 1990s, kava and concoctions made from the plant's component kavalactones were increasingly popular products within global markets for recreational and medicinal drugs. Starting in 2002, however, a number of European countries among others banned kava imports after initial reports that some heavy users suffered liver damage. This has complicated the kava story as producer efforts shifted from protecting rights to the plant to reopening blocked export markets. The difficulty is to both push kava into global markets while protecting local rights to the plant. A promising strategy may be developing consumer awareness of geographic indicators and “noble” kava varieties that Vanuatu's local producers may control yet globally market as “the best in the world.”